Target intelligence / Profile preview

Immunoglobulin heavy variable 6-1 (IGHV6-1)

Target: IGHV6-1
Molecular classification: Immunoglobulin variable region, Immunoglobulin superfamily (IgSF), Antibody variable domain

Overview

Immunoglobulin heavy variable 6-1 (IGHV6-1) is a gene segment encoding a specific variable (V) region of the heavy chain of an antibody (immunoglobulin)[1][2][3]. The V region is essential for determining the antigen-binding specificity of an antibody molecule[1][3]. IGHV6-1 is one of many immunoglobulin heavy chain variable region gene segments that can be recombined with diversity (D) and joining (J) segments in developing B cells to produce a diverse set of antibodies[2][3]. This particular gene segment does not represent a receptor, enzyme, transporter, or other canonical drug target, and there are no drugs known to specifically target IGHV6-1. Rather, IGHV6-1 is a genetic element contributing to the overall diversity of antibody responses[1][2]. It has no direct therapeutic relevance and should not be considered a drug target or receptor.

Other names: IGHV6-1IGHV61VHimmunoglobulin heavy chain variable region

Biological functions

Antigen recognitionImmune response (mediates specificity of antibodies)Adaptive immunity

Disease associations

Other (variable immunoglobulin genes can be associated with immune deficiencies, autoimmune diseases, and certain lymphoid cancers through abnormal recombination or mutation, but IGHV6-1 itself is not a direct disease target)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 6-1 (IGHV6-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 6-1 (IGHV6-1).

Explore the full profile